Latest filings (excl ownership)
EFFECT
Notice of effectiveness
24 Jan 23
POS AM
Prospectus update (post-effective amendment)
20 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jan 23
15-12G
Securities registration termination
17 Jan 23
6-K
Current report (foreign)
13 Jan 23
25-NSE
Exchange delisting
6 Jan 23
6-K
Current report (foreign)
28 Dec 22
6-K
Current report (foreign)
19 Dec 22
6-K
Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review
6 Dec 22
6-K
Current report (foreign)
21 Nov 22
6-K
Unaudited Interim Condensed Consolidated Financial Statements
9 Nov 22
6-K
Current report (foreign)
12 Sep 22
6-K
Current report (foreign)
7 Jul 22
6-K
Current report (foreign)
20 May 22
6-K
Current report (foreign)
5 May 22
6-K
Current report (foreign)
2 May 22
20-F
2021 FY
Annual report (foreign)
8 Apr 22
6-K
Current report (foreign)
22 Feb 22
6-K
Current report (foreign)
27 Jan 22
6-K
Current report (foreign)
20 Jan 22
6-K
Current report (foreign)
10 Jan 22
EFFECT
Notice of effectiveness
27 Dec 21
CORRESP
Correspondence with SEC
21 Dec 21
UPLOAD
Letter from SEC
16 Dec 21
F-3
Shelf registration (foreign)
13 Dec 21
S-8
Registration of securities for employees
13 Dec 21
6-K
Unaudited Interim Condensed Consolidated Financial Statements
12 Oct 21
6-K
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
7 Sep 21
6-K
Interim Condensed Consolidated Statement of Financial Position
31 Aug 21
6-K
Current report (foreign)
8 Jun 21
6-K
Current report (foreign)
28 May 21
6-K
Results of 2021 Annual Meeting of Shareholders
27 May 21
6-K
Current report (foreign)
4 May 21
6-K
Current report (foreign)
15 Apr 21
6-K
Current report (foreign)
15 Apr 21
20-F
2020 FY
Annual report (foreign)
14 Apr 21
6-K
Current report (foreign)
12 Jan 21
6-K
Current report (foreign)
11 Sep 20
6-K
Interim Condensed Consolidated Statement of Financial Position
11 Sep 20
Latest ownership filings
SC 13G/A
Rosetta Capital I, LP
14 Feb 23
SC 13G
StepStone Group LP
29 Dec 22
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 22
SC 13G/A
Newtyn Management, LLC
16 Feb 21
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
11 Feb 21
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
SC 13G
Forward Pharma A/S
14 Feb 20
SC 13G/A
Forward Pharma A/S
14 Feb 19
SC 13G/A
Forward Pharma A/S
4 May 18
SC 13G/A
Forward Pharma A/S
9 Feb 18
SC 13G
Forward Pharma A/S
3 Jan 18
SC 13G
Forward Pharma A/S
13 Feb 15
SC 13G
Forward Pharma A/S
13 Feb 15
SC 13G
Forward Pharma A/S
10 Nov 14